The DOI matches its Crossref record.
Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men
Abstract
The aim of this study was to evaluate the effect of treatment with subcutaneous injections of recombinant human erythropoietin (rhEpo), 20‐40 IU kg−1 body weight, 3 times a week, on resting blood pressure, blood pressure response during submaximal exercise, some haematological parameters, and subjective side‐effects in 15 healthy male subjects. RhEpo increased both haemoglobin (Hb) concentration and haematocrit (Hct) significantly, the values for Hb being 152 ± 4.2 g l−1 before treatment and 169 ± 9.3 g l−1(mean values ± SD) after 6 weeks of rhEpo treatment (P< 0.001). The corresponding values for Hct were 44.5 ± 1.5% and 49.7 ± 1.9% (P< 0.001), respectively. The systolic and diastolic blood pressure values at rest were unchanged after rhEpo treatment. A marked increase in systolic blood pressure was observed during submaximal exercise at 200 W, the initial and final values being 177 ± 14.2 mmHg and 191 ± 19.5 mmHg (P< 0.01), respectively. Heart rate during exercise at 200 W was significantly lower after rhEpo treatment than before it: 144 ± 15 beats min−1 compared to 136 ± 8 beats min−1(P< 0.001). The leucocyte count remained unchanged after rhEpo treatment, but there was a significant decrease (P< 0.05) in the number of lymphocytes. Reticulocyte and platelet counts were unchanged. Serum (S) ferritin decreased from 87.3 ± 41.8 mmol l−1 to 59.3 ± 27.8 mmol l−1 after rhEpo treatment (P< 0.001). Serum‐Na, S‐K, S‐Ca, S‐creatinine, S‐bilirubin, S‐aspartate aminotranferase (ASAT), S‐alanine aminotranferase (ALAT), and S‐lactate dehydrogenase (LD) were unchanged after rhEpo treatment. No subjective side‐effects were reported. In conclusion, low doses of rhEpo increased Hb levels and Hct by more than 10% after 6 weeks. Blood pressure at rest was unchanged, but rhEpo induced a markedly accentuated blood pressure reaction during exercise. A minor decrease in the lymphocyte count was observed, but electrolyte and creatinine levels remained unchanged after rhEpo treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stray-Gundersen, J., Chapman, R. F., & Levine, B. D. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1113 · Cited by 338
Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)
Krapf, R., & Hulter, H. N. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05040908 · Cited by 180
“to approximately 49% in normotensive subjects were reported to be associated with a significant increase in resting mean arterial pressure (MAP) of 6 mmHg when measured by intra-arterial catheter (14), whereas a study using cuff measurements identified a significant exercise-induced increase in mean arterial pressure,…”
Background
Metadata
- Authors
- BERGLUND, B., & EKBLOM, B.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1991-02
- Volume
- 229
- Issue
- 2
- Pages
- 125-130
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1987164286
- Cited by
- 168
- References
- 0
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. https://app.cochat.ai/papers/10.1111/j.1365-2796.1991.tb00319.x
- The paper
- BERGLUND, B., & EKBLOM, B. (1991). Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1991.tb00319.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.